Simon M, Jouet J P, Fenaux P, Pollet J P, Walter M P, Bauters F
Service des Maladies du Sang CHU, Lille, France.
Eur J Haematol. 1987 Sep;39(3):193-6. doi: 10.1111/j.1600-0609.1987.tb00756.x.
16 adult idiopathic thrombocytopenic purpura (ITP) patients, with mean age 51 years, were treated by 5 weekly slow intravenous infusions of vinblastine (0.1 mg/kg). When a complete or partial response (CR or PR) was obtained, slow infusions were repeated at 2-weekly then monthly intervals, as maintenance therapy. In 4 cases with ITP of recent onset, but presenting contraindication or failure to prednisone and high dose intravenous immunoglobulins, CR was obtained in all patients after 4 to 15 days (mean 9.5). Only one of these patients relapsed. In 12 cases of refractory chronic ITP (of whom 10 had been splenectomized), there were 2 CR, 6 PR and 4 failures. The 8 responding patients had a mean interval to response of 20 days. The 6 PR were short and did not exceed 15 days. Our results do not support a superiority of this treatment compared to other modes of administration of vinca alkaloids in ITP (intravenous bolus, vinca loaded platelets).
16例成年特发性血小板减少性紫癜(ITP)患者,平均年龄51岁,接受了5次每周一次的长春碱缓慢静脉输注(0.1mg/kg)治疗。当获得完全或部分缓解(CR或PR)时,作为维持治疗,以每2周然后每月一次的间隔重复缓慢输注。在4例近期发病的ITP患者中,存在使用泼尼松和大剂量静脉注射免疫球蛋白的禁忌证或治疗失败,但所有患者在4至15天(平均9.5天)后均获得CR。这些患者中只有1例复发。在12例难治性慢性ITP患者(其中10例已行脾切除术)中,有2例CR,6例PR和4例治疗失败。8例有反应的患者平均反应间隔为20天。6例PR持续时间短,不超过15天。我们的结果不支持与ITP中长春花生物碱的其他给药方式(静脉推注、长春花负载血小板)相比,这种治疗具有优越性。